Cargando…
Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigen-specific T-cell responses.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782136/ https://www.ncbi.nlm.nih.gov/pubmed/24073370 http://dx.doi.org/10.4161/onci.24882 |